Challenges of evaluating and modelling vaccination in emerging infectious diseases-Reference-Cited by-同舟云学术

Challenges of evaluating and modelling vaccination in emerging infectious diseases

Published:2021-12 Issue: Volume:37 Page:100506
ISSN:1755-4365
Container-title:Epidemics
language:en
Short-container-title:Epidemics

Author:

Madewell Zachary J.,Dean Natalie E.,Berlin Jesse A.,Coplan Paul M.,Davis Kourtney J.,Struchiner Claudio J.,Halloran M. Elizabeth

Funder

National Institutes of Health

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Public Health, Environmental and Occupational Health,Microbiology,Parasitology,Epidemiology

Reference74 articles.

1. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study;Adegbola;Lancet,2005

2. Estimating direct and indirect protective effect of influenza vaccination in the United States;Arinaminpathy;Am. J. Epidemiol.,2017

3. AstraZeneca, 2021. AZD1222 US Phase III primary analysis confirms safety and efficacy [cited 2021 July 31]. https://www.astrazeneca.com/media-centre/press-releases/2021/azd1222-us-phase-iii-primary-analysis-confirms-safety-and-efficacy.html.

4. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N. Engl. J. Med.,2021

5. The challenges of modeling and forecasting the spread of COVID-19;Bertozzi;Proc. Natl. Acad. Sci. USA,2020

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nowcasting and forecasting the 2022 U.S. mpox outbreak: Support for public health decision making and lessons learned;Epidemics;2024-06

2. In silico design and analysis of a multiepitope vaccine against Chlamydia;Pathogens and Disease;2024

3. Modeling Supply and Demand Dynamics of Vaccines against Epidemic-Prone Pathogens: Case Study of Ebola Virus Disease;Vaccines;2023-12-25

4. Influenza Vaccine Effectiveness Against Influenza-Associated Hospitalization in Hong Kong Children Aged 9 Months to 17 Years, March–June 2023;Journal of the Pediatric Infectious Diseases Society;2023-10-11

5. Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants;BMC Infectious Diseases;2023-06-26